Medpace Holdings (MEDP) Share-based Compensation (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Share-based Compensation data on file, last reported at $4.3 million in Q2 2026.

• Quarterly Share-based Compensation fell 26.94% year-over-year to $4.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.2 million (down 47.58% YoY) and the FY2025 annual result came in at $34.8 million, up 36.34% from the prior year.
• Share-based Compensation retreated to $4.3 million in Q2 2026, from $4.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $16.9 million in Q1 2025 to a low of $3.6 million in Q2 2024.
• A 5-year average of $6.2 million and a median of $5.5 million in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2025 — Share-based Compensation jumped 291.93% — and 2026, when it sank 70.89%.
• Tracing MEDP's Share-based Compensation over 5 years: stood at $5.6 million in 2022, then slipped by 7.65% to $5.2 million in 2023, then climbed by 14.02% to $5.9 million in 2024, then fell by 4.57% to $5.6 million in 2025, then retreated by 22.63% to $4.3 million in 2026.
• The last three Share-based Compensation figures came in at $4.3 million (Q2 2026), $4.9 million (Q1 2026), and $5.6 million (Q4 2025), per Business Quant data.